Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Enzyme Inhib Med Chem ; 23(5): 728-38, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18821260

RESUMEN

In this study, the synthetic way to new N-pyridinyl(methyl)indolylpropanamides acting as non acidic NSAIDs has been described. Pharmacomodulation was carried out at N(1) and C(5) of the indole ring and at the level of the propanamide chain. N(3)-pyridinylmethyl-[1(4-chlorobenzyl-5-chloroindol-3-yl)propanamide represents one of the most potent compounds in the TPA-induced mouse ear swelling assay, with a level of activity higher than that of ibuprofen and comparable to that of dexamethasone.


Asunto(s)
Amidas/síntesis química , Indoles/síntesis química , Inflamación/tratamiento farmacológico , Amidas/farmacología , Animales , Dexametasona , Ibuprofeno , Indoles/farmacología , Inflamación/prevención & control , Ratones , Relación Estructura-Actividad
2.
Eur J Med Chem ; 42(5): 686-93, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17316917

RESUMEN

Several N-pyridinyl(methyl)-indol-3-ylpropanamides were synthesized and pharmacological evaluations of their immunosuppressive potential were performed. Among thirteen compounds tested in vitro on murine T proliferation, three showed interesting inhibiting activity. For the most active compound (propanamide 18), immunosuppressive activity was documented both in vitro on human T lymphocytes proliferation and in vivo on mice delayed-type hypersensitivity. These experimental data demonstrated that these compounds hold potential as immunosuppressive agents.


Asunto(s)
Inmunosupresores/farmacología , Indoles/farmacología , Piridinas/farmacología , Amidas/química , Animales , Proliferación Celular , Femenino , Humanos , Hipersensibilidad Tardía , Indoles/química , Ratones , Ratones Endogámicos BALB C , Piridinas/química , Linfocitos T/efectos de los fármacos
3.
J Enzyme Inhib Med Chem ; 21(3): 313-25, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16918079

RESUMEN

New series of 2(or 3)-arylmethylenenaphtho[2,1-b]furan-3(or 2)-ones were synthesized, characterized and tested for anticancer properties in vitro. The target compounds were prepared by Knoevenagel coupling between the naphthofuranones 3, 28-30 and formyl derivatives. 2-(4-Oxo-1-benzopyran-3-ylmethylene)naphtho[2,1-b]furan-3-one 36 was the most active compound (IC50 (L1210) = 1.6 microM). These compounds were also evaluated, in an independent manner, as inhibitors of Src protein tyrosine kinase, but only minor activity was observed.


Asunto(s)
Antineoplásicos/síntesis química , Antineoplásicos/farmacología , Benzofuranos/síntesis química , Benzofuranos/farmacología , Benzopiranos/síntesis química , Benzopiranos/farmacología , Proliferación Celular/efectos de los fármacos , Furanos/síntesis química , Furanos/farmacología , Leucemia L1210/tratamiento farmacológico , Animales , Antineoplásicos/química , Benzofuranos/química , Benzopiranos/química , Línea Celular Tumoral , Cristalografía por Rayos X , Ensayos de Selección de Medicamentos Antitumorales , Furanos/química , Técnicas In Vitro , Ratones , Modelos Moleculares , Estructura Molecular , Naftalenos/síntesis química , Naftalenos/química , Naftalenos/farmacología , Relación Estructura-Actividad , Familia-src Quinasas/antagonistas & inhibidores
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA